<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35182777</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0183</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Autoimmunity reviews</Title><ISOAbbreviation>Autoimmun Rev</ISOAbbreviation></Journal><ArticleTitle>The autonomic aspects of the post-COVID19 syndrome.</ArticleTitle><Pagination><StartPage>103071</StartPage><MedlinePgn>103071</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.autrev.2022.103071</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-9972(22)00041-6</ELocationID><Abstract><AbstractText>The SARS-CoV-2 outbreak, responsible for the widespread COVID-19, led to one of the most rogue pandemics in modern time, yet the major effects of the pandemic may still be ahead of us. SARS-CoV-2 had been found to possess autoimmune properties. Close to 20 distinct autoantibodies which target GPCR of the nervous system and renin-angiotensin system-related molecules were found significantly associated with the clinical severity of COVID-19. The new on-set of more than 10 various autoimmune disorders were documented as well. Additionally, clinical presentations of persisted symptoms were triggered in numerous recently recovered COVID-19 patients, which led to the formulation of the novel term "post-COVID19 syndrome". Manifestations related to post-COVID-19 syndrome exist among approximately 50-80% of symptomatic COVID-19 patients who recovered, and among patients reported more than 50 different long-term effects of the SARS-CoV-2 infection. Many of the common symptoms of the post-COVID19 syndrome are not explained by the virus-related injury alone. Similarly to chronic fatigue syndrome and fibromyalgia, autoimmune-mediated autonomic nervous system dysfunction may play a significant part in the pathogenesis of such symptoms, including chronic fatigue, cognitive impairment, mood related disorders, and numerous more. Importantly, therapeutic options such as immunomodulatory and immunosuppressive therapy may favor some post-COVID19 patients, while plasmapheresis and IVIG could be considered in severe cases. Nevertheless, as physical exercise has been found to stabilize the autonomic nervous system, exercise therapy might be a safer and more effective remedy for the post-COVID19 syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dotan</LastName><ForeName>Arad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ariel University, Israel; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: araddotan@mail.tau.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>David</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnheim</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoenfeld</LastName><ForeName>Yehuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ariel University, Israel; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, 199034, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Autoimmun Rev</MedlineTA><NlmUniqueID>101128967</NlmUniqueID><ISSNLinking>1568-9972</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune disease</Keyword><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Autonomic nervous system dysfunction</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Dysautonomia</Keyword><Keyword MajorTopicYN="N">Fibromyalgia</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Post-COVID19 syndrome</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35182777</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pii">S1568-9972(22)00041-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang Y.C., Lee P.I., Hsueh P.R. Evolving reporting criteria of COVID-19 in Taiwan during the epidemic. J Microbiol Immunol Infect. 2020 Jun;53(3):413&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267588</ArticleId><ArticleId IdType="pubmed">32224117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Ko W.C., Lee P.I., Jean S.S., Hsueh P.R. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020 Aug;56(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243791</ArticleId><ArticleId IdType="pubmed">32450197</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzberger B., Buder F., Lampl B., et al. Epidemiology of SARS-CoV-2. Infection. 2021 Apr;49(2):233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543961</ArticleId><ArticleId IdType="pubmed">33034020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Xu Y., Sun C., et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021 Feb;54(1):12&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227597</ArticleId><ArticleId IdType="pubmed">32425996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.S., Lee J.Y., Yang J.W., et al. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics. 2021;11(1):316&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7681075</ArticleId><ArticleId IdType="pubmed">33391477</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., Bragazzi N.L., Amital H., Shoenfeld Y. Hyperstimulation of adaptive immunity as the common pathway for silicone breast implants, autoimmunity, and lymphoma of the breast. Israel Med Assoc J. 2019 Aug 1;21(8):517&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">31474010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara J.L., Abhyankar S., Gilliland D.G. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplant Proc. 1993 Feb 1;25(1 Pt 2):1216&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">8442093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021 Feb;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 Oct 23;370(6515)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L., Li H., Li L., et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595919</ArticleId><ArticleId IdType="pubmed">33078400</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., Sharif K., O&#x2019;Regan A., Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020 Jun;19(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., Rosenberg V., Tiosano S., et al. Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis. Int J Epidemiol. 2018 Dec 1;47(6):1846&#x2013;1854.</Citation><ArticleIdList><ArticleId IdType="pubmed">30329056</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Kanduc D., Muller S., Makatsariya A., Shoenfeld Y. Molecular mimicry between SARS-CoV-2 and the female reproductive system. Am J Reprod Immunol. 2021 Dec;86(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420155</ArticleId><ArticleId IdType="pubmed">34407240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D., Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res. 2020 Sep 18:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499017</ArticleId><ArticleId IdType="pubmed">32946016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z.-W., Zhang H.-Z., Liu C., Dong K. Autoantibodies in COVID-19: frequency and function. Autoimmun Rev. 2021 Mar;20(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813482</ArticleId><ArticleId IdType="pubmed">33476817</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Garc&#xed;a A., Pham M.M., Crowson C.S., et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 2019;71(9):1545&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717037</ArticleId><ArticleId IdType="pubmed">30957430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui D.T.W., Lee C.H., Chow W.S., et al. Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr Pract. 2021 Sep 1;27(9):894&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257401</ArticleId><ArticleId IdType="pubmed">34237471</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Shoenfeld Y. Post-COVID syndrome: the aftershock of SARS-CoV-2. Int J Infect Dis. 2022 Jan 1;(114):233&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590600</ArticleId><ArticleId IdType="pubmed">34785367</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G., Palmerini F., Ravaglia S., et al. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2. N Engl J Med. 2020 Jun 25;382(26):2574&#x2013;2576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G., Palmerini F., Ravaglia S., et al. Guillain&#x2013;Barr&#xe9; syndrome associated with SARS-CoV-2. N Engl J Med. 2020 Jun 25;382(26):2574&#x2013;2576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo D.A., Centonze D., Alesina A., Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020 Dec 15;173(12):1027&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. 2020 Sep 2:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7464053</ArticleId><ArticleId IdType="pubmed">32876777</ArticleId></ArticleIdList></Reference><Reference><Citation>Akca U.K., Kesici S., Ozsurekci Y., et al. Kawasaki-like disease in children with COVID-19. Rheumatol Int. 2020 Dec;40(12):2105&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492688</ArticleId><ArticleId IdType="pubmed">32936318</ArticleId></ArticleIdList></Reference><Reference><Citation>David P., Dotan A., Mahroum N., Shoenfeld Y. Immune thrombocytopenic purpura (ITP) triggered by COVID-19 infection and vaccination. Isr Med Assoc J IMAJ. 2021 Jun;23(6):378&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">34155853</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., De Marco G., Mahajna H., et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines. 2021 May;9(5):435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146571</ArticleId><ArticleId IdType="pubmed">33946748</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Shoenfeld Y. Perspectives on vaccine induced thrombotic thrombocytopenia. J Autoimmun. 2021 Jul 1;(121)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129886</ArticleId><ArticleId IdType="pubmed">34020254</ArticleId></ArticleIdList></Reference><Reference><Citation>Flatby AV, Himmels JP, Brurberg KG, Gravningen KM. COVID-19: Post COVID-19 condition.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021 Aug 9;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236&#xa0;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021 May;8(5):416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 Nov 1;5(11):1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. Jama. 2020 Aug 11;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R., Rahman M.M., Rassel M.A., et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021 Apr 8;16(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020 Dec;81(6):e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ramadan A., Rabab&#x2019;h O., Shah J., Gharaibeh A. Acute and post-acute neurological complications of COVID-19. Neurol Int. 2021 Mar 9;13(1):102&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006051</ArticleId><ArticleId IdType="pubmed">33803475</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.W.T.W., de Luca R.D., Mello Neto H.O., Barcellos I. Post-COVID-19 syndrome? New daily persistent headache in the aftermath of COVID-19. Arq Neuropsiquiatr. 2020 Nov;78(11):753&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">33331469</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 Jul 1;7(7):611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021 Mar;75(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021 Feb;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021 Apr;174(4):576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021 Feb 1;27(2):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021 Apr;76(4):399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpert G., Amital H., Shoenfeld Y. Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders. Brain Behav Immun - Health. 2020 Mar 3;(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474541</ArticleId><ArticleId IdType="pubmed">34589842</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpert G., Watad A., Tsur A.M., et al. Autoimmune dysautonomia in women with silicone breast implants. J Autoimmun. 2021 Jun;120</Citation><ArticleIdList><ArticleId IdType="pubmed">33799099</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Tai Y., Hu S., et al. Bidirectional role of &#x3b2;2-adrenergic receptor in autoimmune diseases. Front Pharmacol. 2018;9:1313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277539</ArticleId><ArticleId IdType="pubmed">30538630</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Mahroum N., Bogdanos D.P., Shoenfeld Y. COVID-19 as an infectome paradigm of autoimmunity. J Allergy Clin Immunol. 2022 Jan 1;149(1):63&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610602</ArticleId><ArticleId IdType="pubmed">34826507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021 Jan 1;(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Voit-Bak K., Donate T., et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol Psychiatry. 2021 Jun 17:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F., Ciaffi J., Mancarella L., et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 Aug 1;7(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Solano C., Martinez A., Becerril L., et al. Autonomic dysfunction in fibromyalgia assessed by the composite autonomic symptoms scale (COMPASS) J Clin Rheumatol. 2009 Jun 1;15(4):172&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">19342959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Lav&#xed;n M., Hermosillo A.G. Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum. 2000 Feb;29(4):197&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">10707988</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021 Apr;69(2):205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;user W., Ablin J., Fitzcharles A., et al. Fibromyalgia. Nat Rev Dis Primers. 2015 Aug 13;1(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">27189527</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A., Underwood M., Carnes D. Fibromyal Bmj. 2014 Feb 24:348.</Citation><ArticleIdList><ArticleId IdType="pubmed">24566297</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancey J.R., Thomas S.M. Chronic fatigue syndrome: diagnosis and treatment. Am Fam Physician. 2012 Oct 15;86(8):741&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">23062157</ArticleId></ArticleIdList></Reference><Reference><Citation>Brurberg K.G., F&#xf8;nhus M.S., Larun L., Flottorp S., Malterud K. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ Open. 2014 Feb 1;4(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918975</ArticleId><ArticleId IdType="pubmed">24508851</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis Lond Engl. 2021 Oct;53(10):737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C., Loebel M., Freitag H., Krueger A., Bauer S., Antelmann M., et al. Immunoadsorption to remove &#xdf;2 adrenergic receptor antibodies in chronic fatigue syndrome CFS/ME. PLoS One. 2018;13(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854315</ArticleId><ArticleId IdType="pubmed">29543914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig J., Sotzny F., Bauer S., et al. IgG stimulated &#x3b2;2 adrenergic receptor activation is attenuated in patients with ME/CFS. Brain Behav Immun Health. 2020 Mar 1;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474590</ArticleId><ArticleId IdType="pubmed">34589837</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y., Ryabkova V.A., Scheibenbogen C., et al. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol. 2020 May 1;214</Citation><ArticleIdList><ArticleId IdType="pubmed">32171889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal A.S., Bradley A.S., Bishop K.N., Kiani-Alikhan S., Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012 Jan 1;26(1):24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Low P.A., Sandroni P. Postural tachycardia syndrome (POTS) Prim Autonom Nerv Syst. 2012 Jan 1:517&#x2013;519.</Citation></Reference><Reference><Citation>Giacomelli C., Talarico R., Bombardieri S., Bazzichi L. The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management. Expert Rev Clin Immunol. 2013 Nov 1;9(11):1069&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">24168413</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med. 2021 Jan;21(1):e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021 Jan;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2018 Oct 1;16(1):268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus S.E., Tosato G., Armstrong G., et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985 Jan;102(1):7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Grabowski P., Heidecke H., et al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav Immun. 2016 Feb 1;52:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba V., Malkova A., Basantsova N., et al. Classical examples of the concept of the ASIA syndrome. Biomolecules. 2020 Oct;10(10):1436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600067</ArticleId><ArticleId IdType="pubmed">33053910</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning W.T., Kvale H., Kramer P.M., Karabin B.L., Grubb B.P. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies. J Am Heart Assoc. 2019 Sep 17;8(18)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6818019</ArticleId><ArticleId IdType="pubmed">31495251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M., Batizy L., Dasa O., Oostra C., Grubb B. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J SCJ. 2017 Oct;51(5):243&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">28738696</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021 Apr 1;18(4):508&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman B.P., Khoury J.A., Blair J.E., Grill M.F. COVID-19 Dysautonomia. Front Neurol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebel A., Krock E., Gentry C., et al. Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Invest. 2021 Jul 7;131(13)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245181</ArticleId><ArticleId IdType="pubmed">34196305</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen H. Controversies and challenges in fibromyalgia: a review and a proposal. Adv Musculoskelet Dis. 2017 May 1;9(5):115&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5394529</ArticleId><ArticleId IdType="pubmed">28458723</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee K., Wu C.P., Bhardwaj A., Siuba M. Steroids in COVID-19: An overview. Cleve Clin J Med. 2020 Aug 20;(8):1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32819962</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoot T.S., Kerckhoffs A.P., Hilbrands L.B., Van Marum R.J. Immunosuppressive drugs and COVID-19: a review. Front Pharmacol. 2020 Aug 28;11:1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485413</ArticleId><ArticleId IdType="pubmed">32982743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourahmad R., Moazzami B., Rezaei N. Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19. SN Compr Clin Med. 2020 Sep 1;2(9):1407&#x2013;1411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392618</ArticleId><ArticleId IdType="pubmed">32838178</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch A.J., Webber S.C., Brachaniec M., et al. Exercise therapy for fibromyalgia. Curr Pain Headache Rep. 2011 Oct;15(5):358&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165132</ArticleId><ArticleId IdType="pubmed">21725900</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L., Brurberg K.G., Odgaard-Jensen J., Price J.R. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2019;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953363</ArticleId><ArticleId IdType="pubmed">31577366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulcher K.Y., White P.D. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 1997 Jun 7;314(7095):1647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2126868</ArticleId><ArticleId IdType="pubmed">9180065</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade A., Dominski F.H. Infographic. Effects of exercise in patients with fibromyalgia: an umbrella review. Br J Sports Med. 2021 Mar 1;55(5):279&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">32796018</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev. 2009 Jun 1;8(7):569&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">19393212</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith R.L., Bloomfield D.M., Rosenwinkel E.T. Exercise and autonomic function. Coron Artery Dis. 2000 Mar;11(2):129&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">10758814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>